CRBG

Corebridge Financial Inc

Add to Watchlist

Advanced Chart

29.630

-0.720(-2.370%)

Overview
Forecast
Valuation

Line

Candle

YTD

High

29.998

Open

29.470

VWAP

29.49

Vol

3.24M

Mkt Cap

16.37B

Low

29.005

Amount

95.67M

EV/EBITDA(TTM)

8.44

Total Shares

608.44M

29.21B

EV/OCF(TTM)

13.58

P/S(TTM)

0.97

Corebridge Financial, Inc. is a provider of retirement solutions and insurance products in the United States. The Company partners with financial professionals and institutions to help individuals plan, save for and achieve secure financial futures. The Company’s Individual Retirement segment consists of fixed annuities, fixed index annuities, variable annuities, and retail mutual funds. Its Group Retirement segment consists of record-keeping, plan administrative and compliance services, financial planning and advisory solutions offered in-plan, along with proprietary and limited non-proprietary annuities, advisory and brokerage products offered out-of-plan. Its Life Insurance includes products in the United States, including term life and universal life insurance. Its Institutional Markets segment consists of stable value wrap (SVW) products, structured settlement, and pension risk transfer (PRT) annuities, corporate markets products and guaranteed investment contracts (GICs).

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q2

FY2025Q1

5.37B

+18.4%

1.315

-4.71%

5.09B

+21.98%

1.247

+10.38%

5.28B

-9.79%

1.133

+3.02%

Estimates Revision

The market is revising Downward the revenue expectations for Corebridge Financial, Inc. (CRBG) for FY2025, with the revenue forecasts being adjusted by -6.03% over the past three months. During the same period, the stock price has changed by -13.13%.

Revenue Estimates for FY2025

Revise Downward

-6.03%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-8.6%

In Past 3 Month

Stock Price

Go Down

-13.13%

In Past 3 Month

13 Analyst Rating

21.50% Upside

Wall Street analysts forecast CRBG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRBG is 36.00 USD with a low forecast of 28.00 USD and a high forecast of 43.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

11 Buy

1 Hold

1 Sell

Strong Buy

21.50% Upside

Current: 29.630

Low

28.00

Averages

36.00

High

43.00

21.50% Upside

Current: 29.630

Low

28.00

Averages

36.00

High

43.00

Barclays

Alex Scott

Buy

Maintains

$37 → $36

2025-04-11

Reason

Barclays

Alex Scott

Price Target

$37 → $36

2025-04-11

Maintains

Buy

Reason

Barclays lowered the firm's price target on Corebridge to $36 from $37 and keeps an Overweight rating on the shares as part of a Q1 earnings preview for the insurance group. With life earnings facing challenges Barclays favors group benefits, excess capital, and "cheap" cash flows, the analyst tells investors in a research note. The firm says the sector is "navigating uncertainty."

Morgan Stanley

Bob Huang

Buy

Maintains

$43 → $32

2025-04-10

Reason

Morgan Stanley

Bob Huang

Price Target

$43 → $32

2025-04-10

Maintains

Buy

Reason

Morgan Stanley lowered the firm's price target on Corebridge to $32 from $43 and keeps an Overweight rating on the shares. On average across the firm's life insurance coverage, Q1 EPS estimates declined 3% from prior estimates and its 2025 EPS estimates declined 4% from prior estimates, though results vary across companies, notes the analyst in a preview for the group. For underwriting-oriented companies that should not be as sensitive to equity market fluctuations, the firm's estimates generally did not change as much, but it still moved underwriter estimates down as they likely face an incrementally more challenging operating environment, the analyst noted.

Wells Fargo

Elyse Greenspan

Buy

Maintains

$38 → $35

2025-04-10

Reason

Wells Fargo

Elyse Greenspan

Price Target

$38 → $35

2025-04-10

Maintains

Buy

Reason

Wells Fargo lowered the firm's price target on Corebridge to $35 from $38 and keeps an Overweight rating on the shares. The firm notes that the quarter lost a little luster with the tariff backdrop and Wells thinks a bigger focus will be on any views of tariffs/ensuring macro backdrop.

Keefe, Bruyette & Woods

Ryan Krueger

Buy

Maintains

$40 → $37

2025-04-09

Reason

Keefe, Bruyette & Woods

Ryan Krueger

Price Target

$40 → $37

2025-04-09

Maintains

Buy

Reason

Keefe Bruyette analyst Ryan Krueger lowered the firm's price target on Corebridge to $37 from $40 and keeps an Outperform rating on the shares.

UBS

Brian Meredith

Strong Buy

Strong Sell

Downgrades

$40 → $28

2025-04-02

Reason

UBS

Brian Meredith

Price Target

$40 → $28

2025-04-02

Downgrades

Strong Buy

Strong Sell

Reason

UBS downgraded Corebridge to Sell from Buy with a $28 price target.

Piper Sandler

John Barnidge

Buy

Maintains

$35 → $38

2025-04-02

Reason

Piper Sandler

John Barnidge

Price Target

$35 → $38

2025-04-02

Maintains

Buy

Reason

Piper Sandler raised the firm's price target on Corebridge to $38 from $35 and keeps an Overweight rating on the shares. The firm is generally reducing EPS estimates for the group driven by fee and spread headwinds, and favors underwriting areas of lifecoland as a result. Fee businesses have client outflows, less fee and trading days and seasonally higher expenses. Spread has prospect of variable investment income normalization being pushed out, floater impact and possible negative commentary around prospective spread income expectations in Piper's opinion.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Corebridge Financial Inc (CRBG.N) is 5.93, compared to its 5-year average forward P/E of 5.31. For a more detailed relative valuation and DCF analysis to assess Corebridge Financial Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

5.31

Current PE

5.93

Overvalued PE

6.18

Undervalued PE

4.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

4.46

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

8.33

Undervalued EV/EBITDA

0.59

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.68

Current PS

0.00

Overvalued PS

0.79

Undervalued PS

0.58